Use of anti-tuberculosis drugs among newly diagnosed pulmonary tuberculosis inpatients in China: a retrospective study

BACKGROUND: China’s national tuberculosis control program (NTP) provides free, first-line anti-tuberculosis (TB) drugs to pulmonary TB patients. This treatment regimen follows the World Health Organization’s (WHO) guideline. The objective of this paper is to evaluate the current status of anti-TB dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Fei, Zhang, Hui, Lv, Qing, Sato, Kaori D., Qu, Yan, Huan, Shitong, Cheng, Jun, Zhao, Fei, Wang, Lixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720996/
https://www.ncbi.nlm.nih.gov/pubmed/26792535
http://dx.doi.org/10.1186/s40249-016-0098-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720996/
https://www.ncbi.nlm.nih.gov/pubmed/26792535
http://dx.doi.org/10.1186/s40249-016-0098-9

Ejemplares similares